Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing).
Peak oxygen uptake (pVo2) is an important parameter in assessing the functional capacity and prognosis of patients with heart failure. In heart failure trials, change in pVo2 was often used to assess the effectiveness of an intervention. However, the within-subject variability of pVo2 on serial testing may limit its usefulness. This study was designed to evaluate the within-subject variability of pVo2 over 2 baseline cardiopulmonary exercise tests. As a substudy of the HF-ACTION trial, 398 subjects (73% men, 27% women; mean age 59 years) with heart failure and left ventricular ejection fraction < or =35% underwent 2 baseline cardiopulmonary exercise tests within 14 days. Mean pVo2 was unchanged from test 1 to test 2 (15.16 +/- 4.97 vs 15.18 +/- 4.97 ml/kg/min; p = 0.78). However, mean within-subject absolute change was 1.3 ml/kg/min (10th, 90th percentiles 0.1, 3.0), with 46% of subjects increasing and 48% decreasing on the second test. Other parameters, including the ventilation-to-carbon-dioxide production slope and Vo2 at ventilatory threshold, also showed significant within-subject variation with minimal mean differences between tests. In conclusion, pVo2 showed substantial within-subject variability in patients with heart failure and should be taken into account in clinical applications. However, on repeated baseline cardiopulmonary exercise tests, there appears to be no familiarization effect for Vo2 in patients with HF. Therefore, in multicenter trials, there is no need to perform >1 baseline cardiopulmonary exercise test.
Bensimhon
Daniel R
DR
Lebauer Cardiovascular Research Foundation, Greensboro, North Carolina, USA.
Leifer
Eric S
ES
Ellis
Stephen J
SJ
Fleg
Jerome L
JL
Keteyian
Steven J
SJ
Piña
Ileana L
IL
Kitzman
Dalane W
DW
McKelvie
Robert S
RS
Kraus
William E
WE
Forman
Daniel E
DE
Kao
Andrew J
AJ
Whellan
David J
DJ
O'Connor
Christopher M
CM
Russell
Stuart D
SD
D000328:Adult; D000368:Aged; D002245:Carbon Dioxide / Q000378:metabolism; D005080:Exercise Test; D005260:Female; D006333:Heart Failure / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000502:physiology*; D012123:Pulmonary Ventilation / Q000502:physiology; D015203:Reproducibility of Results; D013318:Stroke Volume / Q000502:physiology
D002245:Carbon Dioxide
Am Heart J. 2007 Feb;153(2):201-11
17239677
Am Heart J. 1998 Jan;135(1):107-14
9453529
Chest. 1974 May;65(5):512-7
4826023
Chest. 1984 Sep;86(3):375-82
6467998
J Heart Lung Transplant. 2006 Sep;25(9):1024-42
16962464
Am Heart J. 1997 Jul;134(1):20-6
9266779
Lancet. 1986 Feb 8;1(8476):307-10
2868172
Med Sci Sports Exerc. 1999 Nov;31(11):1623-8
10589867
Chest. 2003 Aug;124(2):720-7
12907564
Eur Heart J. 1990 Jan;11(1):75-81
2106439
Circulation. 1991 Mar;83(3):778-86
1999029
Am J Respir Crit Care Med. 2003 Jan 15;167(2):211-77
12524257
J Appl Physiol (1985). 1986 Jun;60(6):2020-7
3087938
Am J Cardiol. 1998 Oct 1;82(7):905-9
9781977
Chest. 2004 Sep;126(3):942-50
15364777